These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11399647)

  • 1. HGF promotes adhesion of ATP-depleted renal tubular epithelial cells in a MAPK-dependent manner.
    Liu ZX; Nickel CH; Cantley LG
    Am J Physiol Renal Physiol; 2001 Jul; 281(1):F62-70. PubMed ID: 11399647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts.
    Kobayashi E; Sasamura H; Mifune M; Shimizu-Hirota R; Kuroda M; Hayashi M; Saruta T
    Kidney Int; 2003 Oct; 64(4):1179-88. PubMed ID: 12969135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential MAPK pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis.
    Karihaloo A; O'Rourke DA; Nickel C; Spokes K; Cantley LG
    J Biol Chem; 2001 Mar; 276(12):9166-73. PubMed ID: 11118451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor induces MAPK-dependent formin IV translocation in renal epithelial cells.
    O'Rourke DA; Liu ZX; Sellin L; Spokes K; Zeller R; Cantley LG
    J Am Soc Nephrol; 2000 Dec; 11(12):2212-2221. PubMed ID: 11095644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine KC regulates HGF-stimulated epithelial cell morphogenesis.
    Ueland JM; Gwira J; Liu ZX; Cantley LG
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F581-9. PubMed ID: 14600031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor promotes cell proliferation and inhibits progesterone secretion via PKA and MAPK pathways in a human granulosa cell line.
    Taniguchi F; Harada T; Deura I; Iwabe T; Tsukihara S; Terakawa N
    Mol Reprod Dev; 2004 Jul; 68(3):335-44. PubMed ID: 15112327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of ERK accelerates repair of renal tubular epithelial cells, whereas it inhibits progression of fibrosis following ischemia/reperfusion injury.
    Jang HS; Han SJ; Kim JI; Lee S; Lipschutz JH; Park KM
    Biochim Biophys Acta; 2013 Dec; 1832(12):1998-2008. PubMed ID: 23851027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of mitogenesis, motogenesis, and tubulogenesis by hepatocyte growth factor in renal collecting duct cells.
    Cantley LG; Barros EJ; Gandhi M; Rauchman M; Nigam SK
    Am J Physiol; 1994 Aug; 267(2 Pt 2):F271-80. PubMed ID: 8067388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK regulates the hepatocyte growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase.
    Yu CF; Roshan B; Liu ZX; Cantley LG
    J Biol Chem; 2001 Aug; 276(35):32552-8. PubMed ID: 11445578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggravation of necrotic death of glucose-deprived cells by the MEK1 inhibitors U0126 and PD184161 through depletion of ATP.
    Yung HW; Wyttenbach A; Tolkovsky AM
    Biochem Pharmacol; 2004 Jul; 68(2):351-60. PubMed ID: 15194007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Src/kinase/phospholipase C/mitogen-activated protein kinase and induction of neurite expression by ATP, independent of nerve growth factor.
    Lakshmi S; Joshi PG
    Neuroscience; 2006 Aug; 141(1):179-89. PubMed ID: 16730415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
    Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular signaling via ERK/MAPK completes the pathway for tubulogenic fibronectin in MDCK cells.
    Liu Z; Greco AJ; Hellman NE; Spector J; Robinson J; Tang OT; Lipschutz JH
    Biochem Biophys Res Commun; 2007 Feb; 353(3):793-8. PubMed ID: 17196167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway.
    Kakazu A; Chandrasekher G; Bazan HE
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3485-92. PubMed ID: 15452053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells.
    Duan HF; Wu CT; Lu Y; Wang H; Liu HJ; Zhang QW; Jia XX; Lu ZZ; Wang LS
    Exp Cell Res; 2004 Aug; 298(2):593-601. PubMed ID: 15265705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of hepatocyte growth factor-mediated vascular smooth muscle cell migration.
    Ma H; Calderon TM; Kessel T; Ashton AW; Berman JW
    Circ Res; 2003 Nov; 93(11):1066-73. PubMed ID: 14576199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
    Slørdahl TS; Denayer T; Moen SH; Standal T; Børset M; Ververken C; Rø TB
    Eur J Haematol; 2013 Nov; 91(5):399-410. PubMed ID: 23952536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.